Skip to content
TheChatArchiveThe Chat Archive
Grok 4.1 Fast· xaiHugging Face Frontier Reasoning Traces

Build an epilepsy surgical candidate pathway: EMU workup, neuropsych, imaging, and boards.

  1. User

    Build an epilepsy surgical candidate pathway: EMU workup, neuropsych, imaging, and boards.

  2. Assistant

    Epilepsy Surgical Candidate Pathway

    This pathway outlines the standard presurgical evaluation for adult patients with drug-resistant focal epilepsy at a Level 4 Epilepsy Center (per NLAEE guidelines). It integrates EMU workup, neuropsychological testing (neuropsych), advanced imaging, and multidisciplinary boards. The goal is to localize the epileptogenic zone (EZ), assess surgical resectability, predict postoperative outcomes (seizure freedom ~60-80%, depending on pathology), and minimize morbidity.

    The pathway is iterative: Non-invasive Phase I → If inconclusive, Invasive Phase II → Boards → Surgery (if candidate). Total duration: 3-12 months.

    Key Prerequisites

    • Inclusion: Focal epilepsy refractory to ≥2 ASMs (trial of 3rd if needed), seizures ≥2/year impairing QOL, no progressive neurology.
    • Exclusion: Primary generalized epilepsy, non-compliance, active psychiatric contraindications, unrealistic expectations.
    • Team: Epileptologist, neurosurgeon, neuropsychologist, neuroradiologist, neurophysiologist.

    Pathway Flowchart (Text-Based)

    START: Referral for Refractory Focal Epilepsy
    │
    ├── History/Exam + Routine Labs/EEG (outpatient)
    │   └── Discordant? → Optimize ASM → Re-refer
    │
    ▼
    **PHASE I: Non-Invasive Evaluation** (4-8 weeks)
    │
    ├── **Neuropsych Testing** (baseline cognitive map; Wada/fMRI if temporal)
    ├── **Imaging Suite**
    │   ├── 3T MRI (volumetric, epilepsy protocol: T1/T2/FLAIR/SWI)
    │   ├── PET (FDG: hypometabolism)
    │   ├── SISCOM/SPECT (ictal hyperperfusion)
    │   ├── MEG (spike/spike-field)
    │   └── fMRI/DTI (eloquent cortex/tracts)
    └── **EMU Workup (Scalp Video-EEG)** (3-10 days inpatient)
        ├── Capture 3-5 typical seizures + auras
        ├── Interictal spikes
        └── Mapping (phase reversal for central)
    │
    ▼ Decision Point
    └── **EZ Well-Localized + Resectable + >80% VNS-free prediction**?
        ├── YES → **Boards** → Surgery
        └── NO → **PHASE II: Invasive** (or VNS/RNS if non-surgical)
    │
    **PHASE II: Invasive EMU** (1-4 weeks; grids/depths/SEEG)
    ├── Tailored electrode placement (MRI-guided, neuronav)
    ├── Capture seizures → Resection planning
    ├── ECoG mapping (language/motor)
    └── Explant → Repeat Imaging/Neuropsych
    │
    ▼
    **MULTIDISCIPLINARY BOARDS** (Weekly Conference; 1-2 hours/case)
    ├── Present: History, EMU videos/clips, imaging fusion, neuropsych
    ├── Discuss: EZ hypothesis, risks (e.g., 5-10% memory decline temporal), alternatives
    ├── Consensus: 
    │   ├── Surgical Candidate → Proceed (Resection/Laser/DBS)
    │   ├── Borderline → Repeat study/optimize
    │   └── Non-Candidate → Palliative (VNS/RNS/Ketogenic)
    │
    ▼
    **SURGERY** (if approved)
    ├── Pre-op: fMRI/DTI/nav plan
    ├── Post-op: Day 1 EEG/imaging, Neuropsych (1-3 mo), Follow-up EMU (1 yr)
    └── Outcome Metrics: Engel Class I (seizure-free)
    

    Detailed Steps by Component

    1. EMU Workup (Core for Seizure Localization)

    PhaseDurationGoalsOutputs
    Scalp (Phase I)3-10 days3-5 seizures, interictalsOnset/lateralization; SQUID if equivocal
    Invasive (Phase II)7-21 daysPrecise EZ (SOZ)ECoG spikes/seizure onset; functional mapping
    • Safety: AED taper supervised; rescue benzos/MIDazolam; 1:3 nurse ratio.
    • ~30% cases need invasive.

    2. Neuropsychological Testing

    • Timing: Early Phase I + post-invasive.
    • Battery: IQ, memory (verbal/nonverbal), language, executive, attention; IVP/Wada if dominant temporal.
    • fMRI Alternative: Language/memory lateralization (reduces Wada use >70%).
    • Goals: Baseline deficits (IQ drop predicts outcome), post-op risk (e.g., >20% verbal memory risk → hippocampal-sparing).

    3. Imaging Protocol

    ModalityIndicationYield
    3T MRIAllLesion (70% MTS/lesional)
    FDG-PETNon-lesionalConcordance 60-70%
    Ictal SPECT/SISCOMTemporal/non-lesional80% lateralization
    MEGExtra-temporalSpike source 50-70%
    fMRI/DTI/tractographyEloquent-adjacentAvoid deficits
    • Fusion: Coregister all to MRI (e.g., OsiriX/iPlan).
    • Advanced: 7T MRI, AI volumetrics if available.

    4. Multidisciplinary Boards

    • Format: 10-15 min presentation (epileptologist) + discussion.
    • Attendees: 10-20 (neurosurgery, radiology, neuropsych, rehab, nursing).
    • Voting: Consensus; document rationale.
    • Outcomes:
      Decision% CasesNext
      Resectable40-50%OR in 4-6 wks
      Laser/Responsive20%Proceed
      Palliative30%VNS/RNS

    Outcomes & Follow-Up

    • Success: 60-80% Engel I at 1-2 yrs (temporal > extra-temporal).
    • Risks: Infection (1-2% invasive), deficit (5-15%), SD (rare).
    • Audit: Track in EPIC/REDCap; quarterly review.

    This pathway is adaptable (e.g., pediatric: add SISCOM priority). For implementation, integrate into EMR order sets. Questions? 🕵️‍♂️

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.